Cohance Lifesciences Plant Inspected by USFDA; 4 Observations Issued

Cohance Lifesciences Ltd has announced the completion of an inspection by the United States Food and Drug Administration (USFDA) at its formulation (FDF) plant in Shamshabad, Telangana. The inspection, which took place from August 27 to September 4, 2026, concluded with the issuance of a Form FDA 483, detailing four observations. The company has confirmed that it has initiated corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. Cohance Lifesciences reiterated its commitment to quality and regulatory compliance.